ConductScience.org, home

Paper40569488

A Guide to the Evolving Clinical Landscape of Low-Level Viremia Among Persons with HIV in the Modern Treatment Era.

Aldredge A and 3 others. Curr HIV/AIDS Rep, 2025. Cited by 3 papers, by iCite.

Cite this record

ConductScience Library. A Guide to the Evolving Clinical Landscape of Low-Level Viremia Among Persons with HIV in the Modern Treatment Era. Papers, record 40569488. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/40569488

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
A Guide to the Evolving Clinical Landscape of Low-Level Viremia Among Persons with HIV in the Modern Treatment Era.
PubMed
Journal
Curr HIV/AIDS Rep
PubMed
Year
2025
PubMed
Publication types
Journal Article, Review
PubMed
Citations, by iCite
3
iCite
Revised in PubMed
2026-11-03
PubMed

Authors4

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Aldredge AAmalia
2Patel CCorrina
3Sheth ANAnandi N
4Collins LFLauren F

Source PubMed

Download CSV of authors

Topics8

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
HIV InfectionsMajor topic
ViremiaMajor topic
Anti-HIV AgentsMajor topic
Humans
Female
Risk Factors
Viral Load
Male

Source PubMed

Download CSV of topics

Grants4

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated bySource
K23 AG084415NIA NIH HHSUnited StatesK23AG084415PubMed and NIHNIH RePORTER
T32 AI157855NIAID NIH HHSUnited StatesT32AI157855PubMed and NIHNIH RePORTER
P30AI050409Center for AIDS Research, Emory UniversityP30AI050409PubMedNIH RePORTER
K23AG084415National Institute on Aging (NIA) of the NIHK23AG084415PubMed and NIHNIH RePORTER

Download CSV of grants

References134

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
137957382Viral and host mediators of non-suppressible HIV-1 viremia.Nat Med2023https://conductscience.org/library/papers/37957382PubMed
218192682Episodes of low-level viral rebound in HIV-infected patients on antiretroviral therapy: frequency, predictors and outcome.J Antimicrob Chemother2008https://conductscience.org/library/papers/18192682PubMed
338390465Clinical Relevance of Human Immunodeficiency Virus Low-level Viremia in the Dolutegravir era: Data From the Viral Load Cohort North-East Lesotho (VICONEL).Open Forum Infect Dis2024https://conductscience.org/library/papers/38390465PubMed
424361679Incomplete adherence to antiretroviral therapy is associated with higher levels of residual HIV-1 viremia.AIDS2014https://conductscience.org/library/papers/24361679PubMed
536400087Low-level viraemia among people living with HIV in Nigeria: a retrospective longitudinal cohort study.Lancet Glob Health2022https://conductscience.org/library/papers/36400087PubMed
631306175Low-level viremia and virologic failure in persons with HIV infection treated with antiretroviral therapy.AIDS2019https://conductscience.org/library/papers/31306175PubMed
719055701Residual viraemia in HIV-1-infected patients with plasma viral load <or=20 copies/ml is associated with increased blood levels of soluble immune activation markers.Scand J Immunol2008https://conductscience.org/library/papers/19055701PubMed
825664219HIV Drug Resistance Profiles and Clinical Outcomes in Patients with Viremia Maintained at Very Low Levels.World J AIDS2013https://conductscience.org/library/papers/25664219PubMed
934966148Lower Incidence of HIV-1 Blips Observed During Integrase Inhibitor-Based Combination Antiretroviral Therapy.J Acquir Immune Defic Syndr2022https://conductscience.org/library/papers/34966148PubMed
1026165150HIV-1 Very Low Level Viremia Is Associated with Virological Failure in Highly Active Antiretroviral Treatment-Treated Patients.AIDS Res Hum Retroviruses2015https://conductscience.org/library/papers/26165150PubMed
1128299369Socioeconomic status and treatment outcomes for individuals with HIV on antiretroviral treatment in the UK: cross-sectional and longitudinal analyses.Lancet Public Health2016https://conductscience.org/library/papers/28299369PubMed
1239110550Consequences of low-level viremia among women with HIV in the United States.AIDS2024https://conductscience.org/library/papers/39110550PubMed
1337831614Predictors of Post-switch Viremia in People With HIV on Injectable Cabotegravir/Rilpivirine.J Acquir Immune Defic Syndr2024https://conductscience.org/library/papers/37831614PubMed
1426566025Factors Associated with Low-Level Viraemia and Virological Failure: Results from the Austrian HIV Cohort Study.PLoS One2015https://conductscience.org/library/papers/26566025PubMed
1532794406Low-level HIV viremia is associated with low antiretroviral prescription refill rates and social deprivation.AIDS Care2021https://conductscience.org/library/papers/32794406PubMed
1635578387Association of low-level viremia with mortality among people living with HIV on antiretroviral therapy in Dehong, Southwest China: A retrospective cohort study.HIV Med2023https://conductscience.org/library/papers/35578387PubMed
1733331635
Prevalence of drug resistance mutations in HIV-infected individuals with low-level viraemia under combination antiretroviral therapy: an observational study in a tertiary hospital in Northern Taiwan, 2017-19.
J Antimicrob Chemother2021https://conductscience.org/library/papers/33331635PubMed
1824451160HIV drug resistance detected during low-level viraemia is associated with subsequent virologic failure.AIDS2014https://conductscience.org/library/papers/24451160PubMed
1924733471Significance and clinical management of persistent low-level viremia and very-low-level viremia in HIV-1-infected patients.Antimicrob Agents Chemother2014https://conductscience.org/library/papers/24733471PubMed
2037721192Low-level HIV viraemia during antiretroviral therapy: Longitudinal patterns and predictors of viral suppression.HIV Med2024https://conductscience.org/library/papers/37721192PubMed

See all 134 referencesDownload CSV of references

Cited by2

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 3 citations.

PMIDTitleJournalYearIn PapersSource
42713136Residual HIV activity and host immunometabolic remodeling during antiretroviral therapy: implications for cardiovascular-kidney-metabolic risk.Front Immunol2026https://conductscience.org/library/papers/42713136PubMed
42640012Long-Acting Injectable Antiretroviral Therapies for HIV Treatment and Prevention: Clinical Pharmacology, Recent Advances and Future Opportunities.J Clin Pharmacol2026https://conductscience.org/library/papers/42640012PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/40569488

GET https://conductscience.org/api/papers/v1/40569488/references?page=2